Mark S. Shahin, MD

Abington Jefferson Hospital, Sidney Kimmel Medical College of Thomas Jefferson University

Mark Shahram Shahin, MD, FACOG, FACS is Professor of OB GYN at the Sidney Kimmel Medical College of Thomas Jefferson University and is Director of the Hanjani Institute for Gynecologic Oncology at Abington Jefferson Hospital and Deputy Director of the Asplundh Cancer Pavilion of Sidney Kimmel Cancer. He is also enterprise director of Gynecologic Oncology for Jefferson Health.

He received his BS in Bioengineering at Syracuse University, Doctor of Medicine at Northwestern University, his residency in Obstetrics and Gynecology at McGaw Medical Center of Northwestern University and completed two fellowships in advanced gynecologic surgery and gynecologic oncology at the University of Iowa Hospitals and Clinics.

His early research focused on p53 genetic mutations in ovarian malignancies and more recently is focused on drug development in phase II and II trials for ovary and endometrial cancer. Dr. Shahin has authored over 40 manuscripts on treatments of gynecologic cancers and is a principal investigator for NRG Oncology

His clinical interest is in cytoreductive surgery of advanced gynecologic cancers and minimally invasive surgery for gynecologic cancers.

He is a co- chair of the Health Policy Socioeconomic Committee for the Society of Gynecologic Oncology. And also is co-chair of surgical oncology committee of NRG oncology.